Sanofi’s Cenrifki approved in Europe for secondary progressive MS without relapses
SPMS is a debilitating stage of MS where patients experience increasing levels of disability
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Takeda’s new study data for oveporexton shows improvements in narcolepsy type 1
The phase 3 results show improvements in daily function, cognition and nighttime sleep
Lilly to acquire LimmaTech Biologics and Vaccine Company in deals totalling $2.33bn
The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease
Sanofi’s Cenrifki approved in Europe for secondary progressive MS without relapses
SPMS is a debilitating stage of MS where patients experience increasing levels of disability
AbbVie to acquire Apogee Therapeutics in $10.9bn deal
The acquisition includes clinical-stage candidates for atopic dermatitis and asthma
PMEA welcome Simon Bates as new Chair of the judging panel
Roche and Alnylam share their experiences entering the PMEAs
Latest content
Lundbeck appoints Tarek Samad as EVP, Head of Research & Development
Samad previously held senior research leadership positions at Immunitas Therapeutics, Sanofi and Pfizer
Read More
Sanofi appoints Paulo Fontoura as Global Head of R&D
Fontoura previously held senior leadership roles at Xaira Therapeutics and Roche
Read More
Pfizer appoints Cecile Guegan as Interim CFO
Guegan is currently the company’s Senior VP, Finance, Global Biopharmaceutical Business
Read More
Broken String Biosciences appoints Bruce Eaton as Chairman of the Board
Eaton specialises in strategic planning, organisational leadership and commercial execution
Read More
Intelligence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Obesity care in the UK – why it can’t improve until it is recognised as a disease
The WHO classified obesity as a chronic disease over twenty years ago – but UK policy has yet to follow
Read More
The next frontier in clinical trials: navigating multi-disease research with GLP-1s
As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influence a wide range of disease pathways
Read More
Headline trade and market deals are opening doors to greater patient access
Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to therapies
Read More
Men’s health: the gap between awareness and action is where men’s lives are lost
Until the gap between what healthcare systems can offer and how men actually engage with them is closed, outcomes will continue to deteriorate
Read More
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
Blogs
Latest
Genesis Research Group launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026
June 24, 2026 | Genesis Research Group|AI, HEOR, Market Access, RWE, evidence, evidence synthesis, genesis, literature reviews, slr
Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations …
Medscape Education to Showcase the Impact of Neurology CME at EAN 2026
June 23, 2026 | Medscape Education|
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of …
Designing Pharma Stands That People Actually Want to Step Onto
June 18, 2026 | Apex Events and Exhibitions|Exhibition Stand Design, Exhibition Stands, events and exhibitions, pharma exhibitions
Exhibition halls are busy environments where delegates move quickly, often with limited time. For pharmaceutical companies, this presents a challenge: how do you create a …
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
June 17, 2026 | Uniphar|
Strategic partnership enables direct progression to Phase 3, bypassing additional Phase 2 study, as first patients are randomized in global trial TOKYO, Japan and DUBLIN, Ireland — …
Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education
June 16, 2026 | Medscape Education|
Medscape Education has been recognized with 2 prestigious accolades at the Spring 2026 Digital Health Awards. The premier digital education platform earned a Gold Award …
Live Webinar | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
June 18, 2026 | Inizio|
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
The solution: Good localisation doesn’t feel translated
June 18, 2026 | Cuttsy + Cuttsy|Engagement, Inclusion, Localisation, Trusted information, clinical trials, translation
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every …
Good Patient Partnership Guide 2026: Patient Journey Mapping with the Patient Community
June 18, 2026 | Precision AQ|
Patient insight gathering and journey mapping can inform and enhance decision making and initiatives across life sciences. The Good Patient Partnership Guide 2026 brings together …
Healthcare information is becoming easier to access. Trust isn’t.
June 17, 2026 | Cuttsy + Cuttsy|AI, Communications, Digital, health literacy
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
June 17, 2026 | Cuttsy + Cuttsy|ASCO2026, clinical trials
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
Engage Internal Teams Virtually – Engaging Your Advisors Creatively
August 7, 2025 | Impetus Digital | Advisory Boards, Advisory board, Impetus Digital, Life Science Collaboration, MSL, MSL teams, Online advisory board, Pharma, VAB, Virtual advisory board, Virtual collaboration, digital advisory board, medical affairs, pharma advisory board, pharma sales team, pharma team alignment